Bicycle Therapeutics Updates Filing for $80 Million IPO

The company plans to offer 4,333,333 American Depositary Shares and raise a maximum $79,733,328. Bicycle has applied to trade trade on the NASDAQ Global Market under the symbol "BCYC."

Bicycle is a clinical-stage biopharmaceutical company developing a novel class of medicines, which they refer to as Bicycles.